Bart Westerman

18PUBLICATIONS
122CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsPredictive and prognostic markersSurveying (incl. hydrographic surveying)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 30, 2025
Challenges to determine synergistic drug interactions in mice.

Bart A Westerman, Yoran Broersma, Tom Wurdinger

|Aug 20, 2025
Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype.

Fleur M G Cornelissen, Yoran Broersma, Ravi S Narayan

|Aug 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen

|Aug 01, 2025
Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype.

Fleur M G Cornelissen, Yoran Broersma, Ravi S Narayan

|Feb 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification.

Suzanne van der Gaag, Tamara Jordens, Maqsood Yaqub

|Jan 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.

Levi van Hijfte, Marjolein Geurts, Iris de Heer

Pageof 3

Frequent Collaborators

6 joint publications

Pieter Wesseling

4 joint publications

Wies Vallentgoed

4 joint publications

Roel Verhaak

4 joint publications

Pim J French